Effect of monthly intravenous cyclophosphamide in rapidly deteriorating multiple sclerosis patients resistant to conventional therapy (Englisch)
- Neue Suche nach: Khan, O. A.
- Neue Suche nach: Zvartau-Hind, M.
- Neue Suche nach: Caon, C.
- Neue Suche nach: Din, M. U.
- Neue Suche nach: Cochran, M.
- Neue Suche nach: Lisak, D.
- Neue Suche nach: Tselis, A. C.
- Neue Suche nach: Kamholz, J. A.
- Neue Suche nach: Garbern, J. Y.
- Neue Suche nach: Lisak, R. P.
- Neue Suche nach: Khan, O. A.
- Neue Suche nach: Zvartau-Hind, M.
- Neue Suche nach: Caon, C.
- Neue Suche nach: Din, M. U.
- Neue Suche nach: Cochran, M.
- Neue Suche nach: Lisak, D.
- Neue Suche nach: Tselis, A. C.
- Neue Suche nach: Kamholz, J. A.
- Neue Suche nach: Garbern, J. Y.
- Neue Suche nach: Lisak, R. P.
In:
MULTIPLE SCLEROSIS
;
7
;
185-188
;
2001
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:Effect of monthly intravenous cyclophosphamide in rapidly deteriorating multiple sclerosis patients resistant to conventional therapy
-
Beteiligte:Khan, O. A. ( Autor:in ) / Zvartau-Hind, M. ( Autor:in ) / Caon, C. ( Autor:in ) / Din, M. U. ( Autor:in ) / Cochran, M. ( Autor:in ) / Lisak, D. ( Autor:in ) / Tselis, A. C. ( Autor:in ) / Kamholz, J. A. ( Autor:in ) / Garbern, J. Y. ( Autor:in ) / Lisak, R. P. ( Autor:in )
-
Erschienen in:MULTIPLE SCLEROSIS ; 7 ; 185-188
-
Verlag:
- Neue Suche nach: Stockton Press
-
Erscheinungsdatum:01.01.2001
-
Format / Umfang:4 pages
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 616.834 / 362.196834
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 616.834 / 362.196834 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 7
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
Millennium ReflectionsSilberberg, D. et al. | 2001
- 3
-
A meta-analysis of genomic screens in multiple sclerosisThe Transatlantic Multiple Sclerosis Genetics Cooperative et al. | 2001
- 13
-
Chlamydia pneumoniae in multiple sclerosis: humoral immune responses in serum and cerebrospinal fluid and correlation with disease activity markerKrametter, D. / Niederwieser, G. / Berghold, A. / Birnhaum, G. / Strasser-Fuchs, S. / Hartung, H.-P. / Archelos, J. J. et al. | 2001
- 19
-
Raised cerebrospinal fluid nitrite and nitrate levels in patients with multiple sclerosis: no correlation with disease activityDrulovic, J. / Dujmovic, I. / Mesaros, S. / Samardzic, T. / Maksimovic, D. / Stojsavljevic, N. / Levic, Z. / Stojkovic, M. M. et al. | 2001
- 23
-
The predictive value of gadolinium enhancement for long term disability in relapsing-remitting multiple sclerosis - preliminary resultsLosseff, N. A. / Miller, D. H. / Kidd, D. / Thompson, A. J. et al. | 2001
- 27
-
Intra-observer, inter-observer and inter-scanner variations in brain MRI volume measurements in multiple sclerosisGasperini, C. / Rovaris, M. / Sormani, M. P. / Bastianello, S. / Pozzilli, C. / Comi, G. / Filippi, M. et al. | 2001
- 33
-
United States open-label glatiramer acetate extension trial for relapsing multiple sclerosis: MRI and clinical correlatesWolinsky, J. S. / Narayana, P. A. / Johnson, K. P. / Copolymer 1 Multiple Sclerosis Study Group / MRI Analysis Center et al. | 2001
- 43
-
Long-term therapy with glatiramer acetate in multiple sclerosis: effect on T-cellsRagheb, S. / Abramcyzk, S. / Lisak, D. / Lisak, R. et al. | 2001
- 49
-
Interferon beta-1b and intravenous methylprednisolone promote lesion recovery in multiple sclerosisRichert, N. D. / Ostuni, J. L. / Bash, C. N. / Leist, T. P. / McFarland, H. F. / Frank, J. A. et al. | 2001
- 59
-
Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pensionMyhr, K. M. / Riise, T. / Vedeler, C. / Nortvedt, M. W. / Gronning, M. / Midgard, R. / Nyland, H. I. et al. | 2001
- 67
-
Episodic hyperlibidinism in multiple sclerosisde Assis Aquino Gondim, F. / Thomas, F. P. et al. | 2001
- 71
-
Acute pulmonary oedema: presenting symptom of multiple sclerosisCrawley, F. / Saddeh, I. / Barker, S. / Katifi, H. et al. | 2001
- 73
-
Speech and Language Disorders in Multiple Sclerosis (2000)Turkington, L. et al. | 2001
- 75
-
Quantitative contrast-enhanced magnetic resonance imaging to evaluate blood-brain barrier integrity in multiple sclerosis: a preliminary studySilver, N. C. / Tofts, P. S. / Symms, M. R. / Barker, G. J. / Thompson, A. J. / Miller, D. H. et al. | 2001
- 83
-
Water diffusion is elevated in widespread regions of normal-appearing white matter in multiple sclerosis and correlates with diffusion in focal lesionsWerring, D. J. / Clark, C. A. / Droogan, A. G. / Barker, G. J. / Miller, D. H. / Thompson, A. J. et al. | 2001
- 91
-
Additive effect of the HLA-DR15 haplotype on susceptibility to multiple sclerosisRasmussen, H. R. / Kelly, M. A. / Clausen, J. et al. | 2001
- 95
-
Dendritic cells derived from patients with multiple sclerosis show high CD1a and low CD86 expressionHuang, Y.-M. / Kouwenhoven, M. / Jin, Y.-P. / Press, R. / Huang, W.-X. / Link, H. et al. | 2001
- 101
-
Sodium fusidate (fusidin) ameliorates the course of monophasic experimental allergic encephalomyelitis in the Lewis ratDi Marco, R. / Puglisi, G. / Papaccio, G. / Nicoletti, A. / Patti, F. / Reggio, A. / Bendtzen, K. / Nicoletti, F. et al. | 2001
- 105
-
Day-to-day variability of maximum walking distance in MS patients can mislead to relevant changes in the Expanded Disability Status Scale (EDSS): average walking speed is a more constant parameterAlbrecht, H. / Wotzel, C. / Erasmus, L. P. / Kleinpeter, M. / Konig, N. / Pollmann, W. et al. | 2001
- 111
-
An assessment of the spectrum of disability and handicap in multiple sclerosis: a population-based studyMcDonnell, G. V. / Hawkins, S. A. et al. | 2001
- 119
-
Disease specific quality of life instruments in multiple sclerosis: Validation of the Hamburg Quality of Life Questionnaire in Multiple Sclerosis (HAQUAMS)Gold, S. M. / Heesen, C. / Schulz, H. / Guder, U. / Monch, A. / Gbadamosi, J. / Buhmann, C. / Schulz, K. H. et al. | 2001
- 131
-
The relation between objective and subjective impairment in cognitive function among multiple sclerosis patients - the role of depressionMaor, Y. / Olmer, L. / Mozes, B. et al. | 2001
- 137
-
Recovery following acute exacerbations of multiple sclerosis: from impairment to quality of lifeBethoux, F. / Miller, D. M. / Kinkel, R. P. et al. | 2001
- 143
-
In search of a disease marker: the cytokine profile of primary progressive multiple sclerosisNeuhaus, O. / Hartung, H.-P. et al. | 2001
- 145
-
Intracellular cytokine profile in T-cell subsets of multiple sclerosis patients: different features in primary progressive diseaseKillestein, J. / Drijver, B. F. D. / Van der Graaff, W. L. / Uitdehaag, B. M. / Polman, C. H. / Van Lier, R. A. et al. | 2001
- 151
-
Similar pro- and anti-inflammatory cytokine production in the different clinical forms of multiple sclerosisDuran, I. / Martinez-Caceres, E. M. / Brieva, L. / Tintore, M. / Montalban, X. et al. | 2001
- 157
-
Analysis of an interferon-gamma gene dinucleotide-repeat polymorphism in Nordic multiple sclerosis patientsDai, Y. / Masterman, T. / Huang, W. X. / Sandberg-Wollheim, M. / Laaksonen, M. / Harbo, H. F. / Oturai, A. / Ryder, L. P. / Soelberg-Sorensen, P. / Svejgaard, A. et al. | 2001
- 165
-
Uric acid levels in patients with multiple sclerosis: analysis in mono- and dizygotic twinsSpitsin, S. / Hooper, D. C. / Mikheeva, T. / Koprowski, H. et al. | 2001
- 167
-
Ring-enhancement in multiple sclerosis: marker of disease severityMorgen, K. / Jeffries, N. O. / Stone, R. / Martin, R. / Richert, N. D. / Frank, J. A. / McFarland, H. F. et al. | 2001
- 173
-
Clinical, radiological, immunological and pathological findings in inflammatory CNS demyelination - possible markers for an antibody-mediated processBruck, W. / Neubert, K. / Berger, T. / Weber, J. R. et al. | 2001
- 179
-
Double-blind randomized multicenter dose-comparison study of interferon-beta-1a (AVONEX): rationale, design and baseline dataEuropean Study Group on Interferon-Beta-1a in MS et al. | 2001
- 185
-
Effect of monthly intravenous cyclophosphamide in rapidly deteriorating multiple sclerosis patients resistant to conventional therapyKhan, O. A. / Zvartau-Hind, M. / Caon, C. / Din, M. U. / Cochran, M. / Lisak, D. / Tselis, A. C. / Kamholz, J. A. / Garbern, J. Y. / Lisak, R. P. et al. | 2001
- 189
-
Profiles of nursing home residents with multiple sclerosis using the minimum data setBuchanan, R. J. / Wang, S. / Huang, C. / Graber, D. et al. | 2001
- 201
-
Self-administered Expanded Disability Status Scale with functional system scores correlates well with a physician-administered testBowen, J. / Gibbons, L. / Gianas, A. / Kraft, G. H. et al. | 2001
- 207
-
Magnetic Resonance Spectroscopy in Multiple SclerosisBarkhof, F. et al. | 2001
- 209
-
Glatiramer acetate induces a Th2-biased response and crossreactivity with myelin basic protein in patients with MSChen, M. / Gran, B. / Costello, K. / Johnson, K. / Martin, R. / Dhib-Jalbut, S. et al. | 2001
- 221
-
Grey matter abnormalities in multiple sclerosis: proton magnetic resonance spectroscopic imagingSharma, R. / Narayana, P. A. / Wolinsky, J. S. et al. | 2001
- 227
-
Clinical features of multiple sclerosis in a genetically homogeneous tropical populationSanchez, J. L. / Palacio, L. G. / Uribe, C. S. / Londono, A. C. / Villa, A. / Jimenez, M. / Anaya, J. M. / Jimenez, I. / Camargo, M. / Arcos-Burgos, M. et al. | 2001
- 231
-
Reduced quality of life among multiple sclerosis patients with sexual disturbance and bladder dysfunctionNortvedt, M. W. / Riise, T. / Myhr, K.-M. / Landtblom, A.-M. / Bakke, A. / Nyland, H. I. et al. | 2001
- 237
-
Depression during exacerbations in multiple sclerosis: the importance of uncertaintyKroencke, D. C. / Denney, D. R. / Lynch, S. G. et al. | 2001
- 243
-
Interferon beta-1a and depression in relapsing-remitting multiple sclerosis: an analysis of depression data from the PRISMS clinical trialPatten, S. B. / Metz, L. M. et al. | 2001
- 249
-
Physiologic studies of male sexual dysfunction in multiple sclerosisYang, C. C. / Bowen, J. D. / Kraft, G. H. / Uchio, E. M. / Kromm, B. G. et al. | 2001
- 255
-
A new test of memory for multiple sclerosis I: Format development and stimuli designCamp, S. J. / Thompson, A. J. / Langdon, D. W. et al. | 2001
- 263
-
The Brief Repeatable Battery of Neuropsychological Tests: normative values allow application in multiple sclerosis clinical practiceBoringa, J. B. / Lazeron, R. H. / Reuling, I. E. / Ader, H. J. / Pfennings, L. E. / Lindeboom, J. / de Sonneville, L. M. / Kalkers, N. F. / Polman, C. H. et al. | 2001
- 269
-
Multiple sclerosis and oligodendrogliomaGreen, A. J. / Bollen, A. W. / Berger, M. S. / Oksenberg, J. R. / Hauser, S. L. et al. | 2001
- 275
-
Blockade of gamma interferon might be beneficial in MSSteinman, L. et al. | 2001
- 277
-
Randomized study of antibodies to IFN-gamma and TNF-alpha in secondary progressive multiple sclerosisSkurkovich, S. / Boiko, A. / Beliaeva, I. / Buglak, A. / Alekseeva, T. / Smirnova, N. / Kulakova, O. / Tchechomin, V. / Gurova, O. / Deomina, T. et al. | 2001
- 285
-
Anti-MOG and anti-MBP antibody subclasses in multiple sclerosisEgg, R. / Reindl, M. / Deisenhammer, F. / Linington, C. / Berger, T. et al. | 2001
- 290
-
Diffusion tensor imaging in early relapsing-remitting multiple sclerosisGriffin, C. M. / Chard, D. T. / Ciccarelli, O. / Kapoor, R. / Barker, G. J. / Thompson, A. J. / Miller, D. H. et al. | 2001
- 298
-
Modelling new enhancing MRI lesion counts in multiple sclerosisSormani, M. P. / Bruzzi, P. / Rovaris, M. / Barkhof, F. / Comi, G. / Miller, D. H. / Cutter, G. R. / Filippi, M. et al. | 2001
- 305
-
Pirfenidone for chronic progressive multiple sclerosisWalker, J. E. / Margolin, S. B. et al. | 2001
- 313
-
Inactivation of peroxynitrite in multiple sclerosis patients after oral administration of inosine may suggest possible approaches to therapy of the diseaseSpitsin, S. / Hooper, D. C. / Leist, T. / Streletz, L. J. / Mikheeva, T. / Koprowski, H. et al. | 2001
- 320
-
Cardiovascular autonomic dysregulation and fatigue in multiple sclerosisMerkelbach, S. / Dillmann, U. / Kolmel, C. / Holz, J. / Muller, M. et al. | 2001
- 327
-
Autonomic dysfunction in multiple sclerosis is related to disease activity and progression of disabilityFlachenecker, P. / Reiners, K. / Krauser, M. / Wolf, A. / Toyka, K. V. et al. | 2001
- 335
-
Differential treatment effect on measures of neurologic exam, functional impairment and patient self-report in multiple sclerosisHoogervorst, E. L. / Kalkers, N. F. / van Winsen, L. M. / Uitdehaag, B. M. / Polman, C. H. et al. | 2001
- 340
-
Quality of life in multiple sclerosis: the impact of depression, fatigue and disabilityAmato, M. P. / Ponziani, G. / Rossi, F. / Liedl, C. L. / Stefanile, C. / Rossi, L. et al. | 2001
- 345
-
Early prediction of a benign course of multiple sclerosis on clinical grounds: a systematic reviewRamasaransing, G. / Maurits, N. / Zwanikken, C. / De Keyser, J. et al. | 2001
- 349
-
A prospective, open-label treatment trial to compare the effect of IFNbeta-1a (Avonex®), IFNbeta-1b (Betaseron®), and glatiramer acetate (Copaxone®) on the relapse rate in relapsing-remitting multiple sclerosis: results after 18 months of therapyKhan, O. A. / Tselis, A. C. / Kamholz, J. A. / Garbern, J. Y. / Lewis, R. A. / Lisak, R. P. et al. | 2001
- 354
-
Fatigue in progressive multiple sclerosis: results of a randomized double-blind, placebo-controlled, crossover trial of oral 4-aminopyridineRossini, P. M. / Pasqualetti, P. / Pozzilli, C. / Grasso, M. G. / Millefiorini, E. / Graceffa, A. / Carlesimo, G. A. / Zibellini, G. / Caltagirone, C. et al. | 2001
- 359
-
Isolated demyelinating syndromes: comparison of CSF oligoclonal bands and different MR imaging criteria to predict conversion to CDMSTintore, M. / Rovira, A. / Brieva, L. / Grive, E. / Jardi, R. / Borras, C. / Montalban, X. et al. | 2001
- 364
-
Changes in motor cortex activation after recovery from spinal cord inflammationCramer, S. C. / Fray, E. / Tievsky, A. / Parker, R. A. / Riskind, P. N. / Stein, M. C. / Wedeen, V. / Rosen, B. R. et al. | 2001
- 371
-
Chlamydia pneumoniae in the cerebrospinal fluid of patients with multiple sclerosis and neurological controlsSotgiu, S. / Piana, A. / Pugliatti, M. / Sotgiu, A. / Deiana, G. A. / Sgaramella, E. / Muresu, E. / Rosati, G. et al. | 2001
- 375
-
Balo's concentric sclerosis: surviving normal myelin in a patient with a relapsing-remitting clinical courseMoore, G. R. / Berry, K. / Oger, J. J. / Prout, A. J. / Graeb, D. A. / Nugent, R. A. et al. | 2001
- 383
-
Glial toxicity in urine and multiple sclerosisMalcus-Vocanson, C. / Giraud, P. / Micoud, F. / Janin, V. / Charles, M. H. / Broussolle, E. / Chazot, G. / Mandrand, B. / Perron, H. et al. | 2001
- 389
-
Visuoperceptual impairment in MS patients: nature and possible neural originsVleugels, L. / Lafosse, C. / van Nunen, A. / Charlier, M. / Ketelaer, P. / Vandenbussche, E. et al. | 2001
- 402
-
Paroxysmal attacks in multiple sclerosisTuzun, E. / Akman-Demir, G. / Eraksoy, M. et al. | 2001
- 405
-
Factors related to agreement between self-reported and conventional Expanded Disability Status Scale (EDSS) scoresCheng, E. M. / Hays, R. D. / Myers, L. W. / Ellison, G. W. / Beckstrand, M. / Vickrey, B. G. et al. | 2001
- 411
-
The relationship between disability and depression in multiple sclerosis: the role of uncertainty, coping, and hopeLynch, S. G. / Kroencke, D. C. / Denney, D. R. et al. | 2001
- 417
-
Rehabilitation of intimacy and sexual dysfunction in couples with multiple sclerosisFoley, F. W. / LaRocca, N. G. / Sanders, A. S. / Zemon, V. et al. | 2001
-
17th Congress of the European Committee for Treatment & Research in Multiple Sclerosis (ECTRIMS) 12-15 September 2001The Royal Dublin Society et al. | 2001